Wearable Devices for Exercise Prescription and Physical Activity Monitoring in Patients with Various Cardiovascular Conditions
Tasuku Terada, Matheus Hausen, Kimberley L. Way, Carley O’Neill, Isabela Roque Marçal, Paul Dorian, Jennifer L. Reed
Abstract
As wearable technologies have become increasingly affordable, accessible, and practical, an increasing number of people with cardiovascular disease are beginning to use consumer-grade devices.Common health and wellness metrics reported by wearable devices include heart rate, heart rhythm, and step count, which may afford opportunities to assess cardiovascular conditions, prescribe more personalized exercise for enhanced engagement, and monitor physical activity adherence in patients with cardiovascular disease.This narrative review discusses the application of wearable devices in patients with coronary artery disease, heart failure, atrial fibrillation (AF), cardiac implantable electric devices, and peripheral artery disease in different cardiovascular rehabilitation settings (eg, supervised and home-based).Available literature suggests that, when combined with telemonitoring, wearable devices can increase physical activity participation, thereby improving peak oxygen consumption ( _ VO 2peak ) and quality of life (QoL) in patients with coronary artery disease, enhancing physical function and QoL in patients with heart failure, and increasing walking capacity and _ VO 2peak in patients with peripheral R ESUM ELes technologies portables etant devenues de plus en plus abordables, accessibles et pratiques, un nombre croissant de personnes atteintes de maladies cardiovasculaires (MCV) commencent utiliser des dispositifs grand public.Les m etriques de sant e et de bien-tre commun ement rapport ees par les dispositifs portatifs comprennent la fr equence cardiaque (FC), le rythme cardiaque et le nombre de pas, ce qui peut permettre d' evaluer les conditions cardiovasculaires, de prescrire des exercices plus personnalis es pour am eliorer l'engagement et de surveiller l'adh esion l'activit e physique chez les patients atteints de MCV.Cette revue narrative traite de l'application des dispositifs portables chez les patients atteints de maladie coronarienne (MC), d'insuffisance cardiaque (IC), de fibrillation auriculaire (FA), porteurs de dispositifs electroniques cardiaques implantables (DEI), ou atteints de maladie art erielle p eriph erique (MAP) dans diff erents contextes de r eadaptation cardiovasculaire (par exemple, supervis ee et domicile).La litt erature disponible suggre que, lorsqu'ils sont associ es la t el esurveillance, les dispositifs portables peuvent augmenter la participation l'activit e physique, am eliorant ainsi la consommation Cardiovascular disease (CVD) is the leading cause of death globally, responsible for an estimated 17.9 million deaths each year, 1 with 30% of ischemic heart disease cases worldwide being linked to physical inactivity. 2 A supervised cardiovascular rehabilitation (CR) program prevents secondary events and reduces the risk of mortality in patients with CVD. 3 However, centre-based supervised CR is grossly underutilized, due to several barriers, including lack of physician recommendation, limited accessibility, lack of resources (eg, a CJC Open 7 (2025) 695e706